光明中医
光明中醫
광명중의
GUANG MING JOURNAL TRADITIONAL CHINESE MEDICINE
2014年
7期
1387-1389,1394
,共4页
戴明%杨清蓉%钟华成%陈旭兰%黄景东%陈文真%谢剑明
戴明%楊清蓉%鐘華成%陳旭蘭%黃景東%陳文真%謝劍明
대명%양청용%종화성%진욱란%황경동%진문진%사검명
肺癌%金龙胶囊%顺铂%血管内皮生长因子%微血管密度%裸鼠移植瘤
肺癌%金龍膠囊%順鉑%血管內皮生長因子%微血管密度%裸鼠移植瘤
폐암%금룡효낭%순박%혈관내피생장인자%미혈관밀도%라서이식류
Lung cancer%Jin Long Capsule(JLC)%Cisplatin%Vascular endothelial growth factor (VEGF)%Micro-vessel density(MVD)%Nude mice xenografts
目的:探讨金龙胶囊对肺腺癌A549移植瘤生长的抑制作用。方法建立裸鼠移植瘤模型,随机分成阴性对照组( A组)、单药金龙胶囊组(B组)、单药顺铂组(C组)和联合用药组(D组)4组,连续用药4周。观察肿瘤生长情况,计算抑瘤率;免疫组化法检测移植瘤微血管密度(microvessel density,MVD);RT-PCR分析各组治疗后VEGF及凋亡基因Bcl-2mRNA表达情况。结果与阴性对照组比较,金龙胶囊治疗组( B、D组)抑瘤率分别为26.94%、51.61%,联合用药组( D组)效果最佳。治疗组微血管密度分别为18.83±0.75、14.17±0.75,联合用药组最为显著,而单药顺铂组与对照组在抑瘤率和微血管密度表达上均无差异( P>0.05)。金龙胶囊治疗组(B、D组)Bcl-2mRNA表达较对照组有显著差异(P<0.001),但两组之间无差异(P=0.369);四组之间在VEGFmRNA表达上无明显差异( P>0.05)。结论金龙胶囊对荷A549裸鼠移植瘤有抑制作用,联合顺铂用药有显著协同作用,其作用机制可能与抑制肿瘤微血管形成、诱导细胞凋亡增加有关。
目的:探討金龍膠囊對肺腺癌A549移植瘤生長的抑製作用。方法建立裸鼠移植瘤模型,隨機分成陰性對照組( A組)、單藥金龍膠囊組(B組)、單藥順鉑組(C組)和聯閤用藥組(D組)4組,連續用藥4週。觀察腫瘤生長情況,計算抑瘤率;免疫組化法檢測移植瘤微血管密度(microvessel density,MVD);RT-PCR分析各組治療後VEGF及凋亡基因Bcl-2mRNA錶達情況。結果與陰性對照組比較,金龍膠囊治療組( B、D組)抑瘤率分彆為26.94%、51.61%,聯閤用藥組( D組)效果最佳。治療組微血管密度分彆為18.83±0.75、14.17±0.75,聯閤用藥組最為顯著,而單藥順鉑組與對照組在抑瘤率和微血管密度錶達上均無差異( P>0.05)。金龍膠囊治療組(B、D組)Bcl-2mRNA錶達較對照組有顯著差異(P<0.001),但兩組之間無差異(P=0.369);四組之間在VEGFmRNA錶達上無明顯差異( P>0.05)。結論金龍膠囊對荷A549裸鼠移植瘤有抑製作用,聯閤順鉑用藥有顯著協同作用,其作用機製可能與抑製腫瘤微血管形成、誘導細胞凋亡增加有關。
목적:탐토금룡효낭대폐선암A549이식류생장적억제작용。방법건립라서이식류모형,수궤분성음성대조조( A조)、단약금룡효낭조(B조)、단약순박조(C조)화연합용약조(D조)4조,련속용약4주。관찰종류생장정황,계산억류솔;면역조화법검측이식류미혈관밀도(microvessel density,MVD);RT-PCR분석각조치료후VEGF급조망기인Bcl-2mRNA표체정황。결과여음성대조조비교,금룡효낭치료조( B、D조)억류솔분별위26.94%、51.61%,연합용약조( D조)효과최가。치료조미혈관밀도분별위18.83±0.75、14.17±0.75,연합용약조최위현저,이단약순박조여대조조재억류솔화미혈관밀도표체상균무차이( P>0.05)。금룡효낭치료조(B、D조)Bcl-2mRNA표체교대조조유현저차이(P<0.001),단량조지간무차이(P=0.369);사조지간재VEGFmRNA표체상무명현차이( P>0.05)。결론금룡효낭대하A549라서이식류유억제작용,연합순박용약유현저협동작용,기작용궤제가능여억제종류미혈관형성、유도세포조망증가유관。
Objective To explore the effect of Jin Long Capsule with or without cisplatin ( DDP) on tumor growth of lung adenocarcinoma A549 cell xenografts in nude mice .Methods After a model of human lung cancer established by subcutaneous transplantation of A 549 cells in nude mice, 24 mice were randomly divided into control group (A group), Jin Long Capsule group(B group), DDP group(C group) and combination treatment group(D group).Treatment continued for 4 weeks.Inhibition rates were evaluated, tumor micro-vessel density(MVD) were determined by immune-histochemistry, the mRNA expression of VEGF and apoptosis-associated gene(Bcl-2) were assessed by RT-PCR analyses.Results The tumor growth inhibition rates of Jin Long Capsule treatment groups ( B、D groups ) were 26.94% and 51.61%respectively, and more effect in combination group .The expression of MVD in two groups above-mentioned were 18.83 ±0.75 and 14.17 ± 0.75 respectively.No statistically difference were seen between DDP group and control group .Compared to control group, RT-PCR analyses revealed a decrease in expression of Bcl-2 genes in A549 tumors by Jin Long Capsule treatment groups ( B、D groups ) , and no statistically difference in these two groups .Either group showed no statistically difference in VEGF mRNA expression .Conclusion Jin Long Capsule has inhibitory effect , and has synergetic effect with traditional chemotherapy on tumor growth of lung adencarcinoma A 549 cell xenografts in nude mice through inhibiting angiogenesis , and may enhance the sensitivity of A 549 cells to DDP by inducing cell apoptosis .